Tilomisole manufacturers
- Tilomisole
-
- $162.00
-
2026-05-11
- CAS:58433-11-7
- Purity: 99.21%
- Supply Ability: 10g
|
| | Tilomisole Basic information |
| Product Name: | Tilomisole | | Synonyms: | Tilomisole;Thiazolo[3,2-a]benzimidazole-2-acetic acid, 3-(4-chlorophenyl)- | | CAS: | 58433-11-7 | | MF: | C17H11ClN2O2S | | MW: | 342.8 | | EINECS: | | | Product Categories: | | | Mol File: | 58433-11-7.mol |  |
| | Tilomisole Chemical Properties |
| | Tilomisole Usage And Synthesis |
| Uses | Tilomisole (Wy 18251) is a benzimidazothiazole experimental agent with anti-inflammatory activity. Tilomisole causes less agranulocytosis than levamisole, but retains immunomodulating capabilities. Tilomisole is orally active. Tilomisole has the potential for the research of cancer and inflammation[1][2]. | | References | [1] Dillman RO, et al. WY 18,251 (Tilomisole), an analog of levamisole: tolerability, and immune modulating effects in cancer patients. Mol Biother. 1992;4(1):10-14. PMID:1385709
[2] Darwish SA, et al. New tilomisole-based benzimidazothiazole derivatives as anti-inflammatory agents: Synthesis, in vivo, in vitro evaluation, and in silico studies [published online ahead of print, 2022 Jan 29]. Bioorg Chem. 2022;120:105644. DOI:10.1016/j.bioorg.2022.105644 |
| | Tilomisole Preparation Products And Raw materials |
|